Introduction
In general, it is believed that HIV-1 enters the brain at an early stage of infection and resides primarily in a limited number of macrophage/microglia and astrocytic cells. Many soluble cellular factors as well as viral proteins from the resident-infected cells have been proposed to contribute to the neuronal damage and dysfunction (Kaul et al., 2001) . However, the mechanism(s) leading to neuronal dysfunction and injury remain unclear. One of the viral proteins that strongly affect neuronal survival and function is Tat, which is expressed at an early stage of viral infection and plays a pivotal role in transcriptional activation of HIV-1-LTR (Gaynor, 1995) . By interacting with different host proteins, Tat has been shown to promote survival and proliferation in various cell types (Ensoli et al., 1993; Zauli et al., 1993 Zauli et al., , 1995 Lotz et al., 1994; Seve et al., 1999; Cantaluppi et al., 2001) , and in some cases promote apoptosis (Nath et al., 1996; Kruman et al., 1998) . There is a growing line of evidence supporting the functional crosstalk between nerve growth factor (NGF) action and HIV-1 infection. For instance, Tat cooperates with NGF to induce HIV gene expression and replication in neuronal and glial cells with an immature phenotype (Ensoli et al., 1994) , NGF activates HIV-LTR in a neuronal cell model (Recio and Aranda, 1997) , and neurotrophins, including NGF, prevent Tat-induced neuronal apoptosis (Ramirez et al., 2001) .
The rat pheochromocytoma cell line PC12 is a wellestablished model for studying the NGF network of signal transduction pathways in neuronal cells (Klesse et al., 1999) . NGF binds to and activates the TrkA receptor, which in turn phosphorylates and activates several substrates including Shc, PLC-g, and PI3-kinase, which consequently activate MAPK/ERK, PKC, and Akt (Klesse et al., 1999) , respectively. The activation of the NGF/TrkA pathway also leads to the transient and tightly regulated expression of early response genes, such as inhibitor of differentiation (Id) proteins, which are necessary for the appropriate development and differentiation of the neuronal phenotype (Nagata and Todokoro, 1994; Einarson and Chao, 1995) . The Id proteins belong to the helix-loop-helix (HLH) family of transcription factors, which lack a DNA-binding domain. By heterodimerizing with basic HLH (bHLH) proteins, Id proteins inhibit their binding to DNA (Benezra et al., 1990a) . Targeted disruption of a member of the Id family, Id1, in mice showed its necessity in maintaining the timing of neuronal differentiation in the embryo (Lyden et al., 1999) . It was also reported that a subset of bHLH genes regulate the choice of neuronal versus glial fate, and that improper expression of Id1 can be deleterious to the survival of differentiating neurons (Cai et al., 2000) . Besides its negative role in differentiation, the persistent expression of Id1 has been associated with a more invasive (Desprez et al., 1998) and aggressive phenotype of human breast cancer cells (Lin et al., 2000) .
While the activation of signal transducer and activator of transcription factors (Stat) has been extensively investigated in hematopoietic cells, very little is known on their activation in neuronal cells. In contrast, there is a growing line of evidence that the Jak/Stat pathways are active in brain tissue, and potentially influence neuronal survival and differentiation (De-Fraja et al., 2000) . Stats are rapidly phosphorylated on tyrosine residues in response to cytokine and growth factor stimulation. Tyrosine phosphorylation and subsequent SH2-domain-mediated homo-or heterodimerization of Stats are essential for translocation to the nucleus and the activation of transcription. Dysregulation of Stat pathways has been shown to contribute to cancer (Bowman et al., 2000) and virally induced disease in human (Bovolenta et al., 1999 (Bovolenta et al., , 2002 Nguyen et al., 2002) including HIV-1 infection (Bovolenta et al., 1999) .
In this study, we assessed the involvement of Id and Stat proteins in the Tat-mediated dysregulation of neuronal cell behavior using PC12 cell system. The expression of Tat in PC12 cells enhanced the transformed phenotype of the cells and blocked the NGF-mediated differentiation program. The elevated levels of Id1 after serum withdrawal in cells expressing Tat strongly correlate with the ability of these cells to proliferate in the absence of serum and NGF. Furthermore, in the presence of Tat the signals from the NGF cascade are shifted toward the activation of a noncanonical pathway, which leads to Stat5a activation, Id1 expression, and negative effects on neuronal differentiation.
Results

Tat affects PC12 neuronal cell proliferation and differentiation
We utilized a retroviral transduction system to create a population of PC12 cells expressing Tat. The expression of Tat in PC12 cells (PC12/Tat) was determined by Western blot analysis (Figure 1a) . The biological activity of Tat was verified by transcriptional activation of HIV-1 LTR in transfection assay (data not shown). In the first series of experiments, we investigated the ability of PC12/Tat cells to differentiate in response to NGF. As expected, 96 h after NGF stimulation, PC12 and PC12 transduced with the empty vector (PC12/EV) cells completely extended neurites to resemble sympathetic neurons (Figure 1b) . Under similar conditions PC12/Tat showed no response to NGF-induced differentiation (Figure 1b) . Following NGF treatment, PC12 cells showed a reduction of the cell body and the formation of long processes. Instead, PC12/Tat cells showed a bigger cell body and a high tendency to form clusters, a phenotype that is not observed during the course of neuronal cell differentiation, and in differentiated neurons. The quantitative assessment of the neuron-like processes was determined as described in Materials and methods and revealed more then 80% inhibition of differentiation in PC12/Tat cells when compared to PC12 or PC12/EV control cell line (Po0.001, Table 1 ). We next evaluated the growth of PC12 and PC12/Tat cells in serum-free conditions and found that, unlike the parental PC12 cells, PC12/Tat cells gained the ability to grow in the absence of serum (Figure 1c ). Although PC12 cells are already transformed, we have tested the ability of Tat-expressing PC12 cells to form colonies in soft agar. Figure 1d clearly shows that PC12/Tat cells formed almost 10 times more colonies in soft agar when compared to PC12 parental cells or PC12/EV. The ability of Tat to confer a more aggressive phenotype was assessed by testing subcutaneous (s.c.) growth of PC12 and PC12/Tat cells in nude mice. In comparison to parental PC12 or PC12/EV control cells, PC12/Tat cells formed s.c. tumors that were noticeably larger (approximately three times) than those in the absence of Tat (Figure 1e ). Our results are consistent with the earlier report , suggesting that the expression of Tat in PC12 cells blocks the NGF-induced neuronal outgrowth. According to our results, Tat has the ability to enhance the transformed phenotype both in cell culture and in experimental animals.
Tat dysregulates Id1 expression
The downregulation of Id1 expression is required for cell-cycle withdrawal and differentiation in a number of cell types, including neuronal cells (Cordle et al., 1991; Wilson et al., 1991; Kreider et al., 1992; Nagata and Todokoro, 1994; Desprez et al., 1995; Einarson and Chao, 1995) . Of interest, in PC12 cells treated with NGF, a burst of Id1 expression precedes its downregulation (Nagata and Todokoro, 1994) , thus generating a wave of expression. Conversely, persistent levels of Id proteins have been observed in a range of actively proliferating tissues and in some tumor cell lines (Benezra et al., 1990b; Riechmann et al., 1994) . We investigated the expression of Id1 in PC12 and PC12/Tat cells, and evaluated the ability of Tat in affecting Id1 expression. Figure 2a shows the results from Northern blot analysis of Id1 RNA levels in PC12, PC12/EV and PC12/Tat cells at the indicated time points following NGF stimulation. In PC12 and PC12/EV cells low levels of Id1 RNA were detected in SFM, its level increased after 1 hof treatment with NGF, and rapidly declined after 3 h. In PC12/Tat cells, Id1 RNA levels were higher in SFM than that seen in PC12 and PC12/EV cells under HIV-1 Tat and neuronal signaling V Bergonzini et al the same conditions. The level of Id1 RNA was significantly increased within 1 h from NGF treatment, and slightly decreased after 3 h from NGF treatment.
Results from the densitometric analysis of the Id1 RNA levels at various time points in PC12, PC12/EV and PC12/Tat cells showed the greatest difference at 1 and 3 h from NGF treatment with more than threefold increase in PC12/Tat cells ( Figure 2b ). As shown in Tat-expressing cells, the treatment of PC12 cells with 10 ng/ml of recombinant Tat (kindly provided by Dr Rappaport's laboratory) caused a noticeable increase in the expression of Id1 at 1, 3 and 24 h after NGF addition ( Figure 2e ). Owing to the short half-life of the recombinant Tat, longer time points were not considered in this experiment. The ability of Tat to regulate positively Id1 promoter activity was further confirmed in Tat-treated PC12 cells ( Figure 2f ). After serum starvation, PC12 cells were incubated for 3 h with fresh SFM in the absence or presence of NGF and recombinant Tat (10 ng/ml). The data represent the results from three independent experiments.
These data indicate a strong correlation between the high levels of Id1 expression in PC12/Tat cells and the Tat-mediated effect of serum-independent proliferation. To further investigate the role of Id1 dysregulation in neuronal cell proliferation, PC12 cells were transduced with a retrovirus expressing Id1 and higher production of the protein was verified by Western blot (Figure 3a) . The presence of exogenous Id1 in PC12 cells allowed these cells to proliferate in SFM ( Figure 3b ) for up to 96 h. However, under anchorage-independent conditions, PC12/Id1 cells failed to enhance colony formation (data not shown), indicating that overproduction of Id1 although inducing cell proliferation it did not fulfill all Cells were stimulated with NGF after overnight incubation in SFM and lysed as previously described at the indicated time points (1, 24 or 96 h). Anti-Grb2 antibody was used to confirm equal loading. (d) A functional study to determine the effects of Tat on Id1 promoter. PC12, PC12/EV and PC12/Tat cells were transiently transfected using the full-length Id1 promoter. After overnight serum starvation, cells were exposed to NGF for the indicated time points and lysed to perform the luciferase assay as described in Materials and methods. The data represent the averages of five independent experiments. The luciferase values were normalized for the bgalactosidase and are represented as arbitrary units. (e) Western blot analysis of Id1 protein in NGF-stimulated PC12 cells in the presence or absence of 10 ng/ml of recombinant Tat (rec Tat, see Materials and methods). After serum starvation, cells were incubated with NGF (50 ng/ml), with or without Tat, for the indicated time points. (f) Id1 promoter activity in PC12 cells treated with recombinant Tat HIV-1 Tat and neuronal signaling V Bergonzini et al the requirements for transformation. Therefore, Tatmediated mechanism/s that are different from Id1 are likely involved in supporting transformation. In addition, PC12/Id1 cells, like PC12/Tat cells, showed a blockage of differentiation (see Figure 3c and Table 1 ). The importance of Id1 expression to maintain PC12/ Tat phenotype was further investigated by expressing an antisense Id1 mRNA. A retroviral plasmid containing a short Id1 sequence in the antisense orientation was introduced into PC12/Tat cells. The same Id1 sequence introduced in the sense orientation served as negative control. Figure 3d shows the reduced level of Id1 in cells containing Id1 AS (PC12/Tat/Id1 AS) as detected by Western blot analysis. In contrast to PC12/Tat cells, and consistent with PC12 cells or PC12/Tat/Id1 sense control, PC12/Tat/Id1 AS cells failed to survive in the absence of serum (data not shown). Although the antisense Id1 RNA did not shutdown completely the expression of Id1 protein (Figure 3d) , it was sufficient to restore the transient expression of Id1 (the wave of Id1). As shown in Figure 4e , low level of Id1 was present in SFM, it increased at 1 h following the treatment with NGF and it decreased thereafter. Furthermore, similarly to PC12 cells, treatment of PC12/Tat/Id1 AS cells with NGF activated the differentiation program and these cells extended efficiently neuronal processes ( Figure 3f and Table 1 ). As expected, the PC12/Tat/sense control cells did not extend neurites in response to NGF treatment (Table 1) .
NGF-induced activation of Stat5a and Stat5b
The major known substrates for activated TrkA are Shc/ Ras/MAPK and PI3-K/Akt, and there are only few reports about the NGF-mediated activation of Stats in PC12 cells Bradshaw, 1996, 2000; Zhong et al., 2001) . As the inappropriate activation of the Stats has been shown to block cellular differentiation (reviewed (Moriggl et al., 1996) . As shown in Figure 5a (Figure 5b) . Instead, the presence of DN Stat5b had very little or no effect on PC12/Tat differentiation, as also revealed by quantitative analysis (see Table 1 ). In an alternative approach, the constitutively active mutant of Stat5a, Stat5a1*6, was introduced into parental PC12 cells, where Stat5a is not phosphorylated by NGF (Figure 4) . Figure 5c shows levels of expression of the Stat5a1*6 in PC12 cells. Stat5a1*6 is fused to the EGFP, thus resulting in a higher molecular weight. In contrast to PC12 cells and consistent with PC12/Tat cells, PC12/ Stat5a1*6 cells showed no response to NGF-induced differentiation (Figure 5d) .
Results from the above studies show that by affecting the function of Id1 and Stat5, Tat may interfere with NGF signaling pathway necessary for the differentiation of PC12 cells. To further explore potential communication between these two regulatory molecules, we investigated the role of Stat5 in Tat-mediated activation of Id1 promoter. As shown in Figure 6a , expression of DN Stat5a, but not Stat5b in PC12/Tat cells, caused a noticeable decrease in Tat Figure 2c ) rather than PC12 parental cells. High levels of Id1 are present after serum withdrawal (Stat5a is constitutively activated in these cells) and they persist up to 3 h from NGF addition. Altogether, these 
Discussion
It is accepted that HIV-1 enters the central nervous system through infected monocytes, which actively release cellular neurotoxins such as tumor necrosis factor a (TNFa) and viral proteins including gp120 and Tat. Earlier studies report that Tat, a potent stimulator of the cellular neurotoxic proteins such as TNFa gene (Sastry et al., 1990; Chen et al., 1997) , exhibits the ability to cause neuronal cell damage and apoptosis through mechanisms that are independent of TNFa pathway (Merrill et al., 1992; Chen et al., 1997; Shi et al., 1998) . In addition to its proapoptotic properties, an increasing number of reports ascribed a role for Tat in enhancing cell proliferation (Lotz et al., 1994; Cantaluppi et al., 2001) . The complex relationship between neuronal signaling and neuronal damage induced by HIV-1 prompted us to investigate the participation of Tat in the NGF/TrkA signaling pathways. We used a well-established PC12 cell model for neuronal differentiation to study the interplay between HIV-Tat and NGF. PC12 is a rat pheochromocytoma cell line that can be differentiated toward neuronal lineage upon treatment with NGF. Previous work showed that treatment of PC12 cells with recombinant Tat prevents their ability to differentiate and increases their proliferation rate . We confirmed and extended these data and show that Tat enhances the transformed phenotype of PC12 cells. While parental PC12 cells are dependent on serum for their growth, PC12/Tat cells gained the ability to proliferate in the absence of serum. Also, in anchorage-independent conditions PC12/Tat cells formed a significantly higher number of colonies than PC12 cells. Finally, in vivo experiments in immunodeficient mice showed that Tat increased the size of the tumors formed by PC12 cells. According to our results PC12/Tat cells proliferate at a higher rate than PC12 parental cells, even in the absence of a mitogenic signal (Figure 1c) . We further investigated the molecular mechanisms that are involved in Tat-mediated effects on PC12 cells. In our earlier investigations involving the analysis of the Ras/ MAPKs and of the PI-3K pathways, we found no noticeable activation of ERKs or AKT in PC12/Tat cells maintained in SFM (data not shown), suggesting that the proliferation in SFM may not involve the activation of the Ras or the PI-3K pathways in the absence of any growth factor. This is an interesting observation in light of the previous reports showing that treatment of PC12 cells with recombinant Tat or ectopic expression of Tat leads to the activation of signaling molecules, such as PKC, PI-3K and p125FAK (Milani et al., 1996 (Milani et al., , 1998 Borgatti et al., 1998) . However, it should be noted that in previous studies cells were analysed after 40-48 h of serum starvation, whereas our experiments, due to massive cell death at 48 h, were performed at 16 h after serum withdrawal. Thus, the cell conditions and the experimental time points may account for the observed differences in the activation of various signaling pathways. We further expanded our observation to the analysis of earlier markers for neuronal differentiation, which revealed a serum-independent expression of a cell-cycle-related protein Id1 in PC12/Tat cells (Figure 2a) . Along with the notions that Id1 downregulation is required for cell-cycle withdrawal during differentiation (Norton et al., 1998) and the high Id1 expression levels found in proliferating, undifferentiated cells (Israel et al., 1999) , Id1 was our candidate for the effects of Tat with respect to neuronal proliferation in the absence of growth factor stimulation. In other words, in our system-elevated expression of Id1 substitutes for growth factor-activated signaling, and acts directly at the level of gene expression. Indeed, our data demonstrated that Tat could modulate Id1 expression in PC12 neuronal cell model, leading to dramatic functional changes. The results obtained using recombinant Tat emphasize the involvement of Id1 dysregulation in neuronal cells exposed to exogenous Tat (Figure 2 ). The differentiation program promoted by NGF in PC12 cells induces a burst of expression followed by a downregulation of Id1 protein (Nagata and Todokoro, 1994, and Figure 2c ). In contrast, high levels of Id1 expression in PC12/Tat cells prevent the NGF-induced differentiation program.
Our results show a strong activation of Stat5 proteins in PC12 cells following NGF treatment. In comparison to parental PC12 cells, where NGF treatment leads to the phosphorylation of Stat5b isoform, treatment of PC12/Tat cells with NGF induces phosphorylation of both Stat5a and Stat5b, suggesting a role for Stat5a in the Tat-induced perturbation of NGF/TrkA signaling. Of note that Stat5a and Stat5b, which share significant homology, are differentially expressed in various tissues and exhibit distinct DNA-binding specificities (Caldenhoven et al., 1998) , suggesting that these two members of the Stat family may have distinct functions in processes linked to cell differentiation. The blockage of NGF-induced differentiation was not dependent on the levels of expression of Stat5a or Stat5b proteins in PC12/Tat cells, since the overexpression of wild-type Stat5a or Stat5b in these cells did not change the morphological response to NGF (data not shown). Instead, the introduction of a DN Stat5 led to clarification of the role of Stat5 activation in PC12/ Tat. In fact, our findings indicate that Stat5a activation is required for Tat to inhibit the NGF-induced differentiation of neuronal cells. In parental PC12 cells, the activation of Stat5b might be required for the initial burst of growth and subsequent NGF-dependent differentiation. In PC12/Tat cells the activation of Stat5a, by heterodimerizing with Stat5b, may counteract the positive effect of Stat5b on differentiation (Groner et al., 2000) . Alternatively, in PC12/Tat cells Stat5a may utilize a Stat5b-independent pathway and directly target its downstream genes. In support of this hypothesis earlier studies have shown that Stat5a induces Id1 transcription by recruitment of HDAC1 and deacetylation of C/EBPb (Min Xu et al., 2003) . Hence, our results show that Stat5a positively affects NGF-induced Id1 promoter activation.
In this study, we investigated the role of Id1 dysregulation in PC12/Tat cells with respect to serumindependent proliferation and blockage of NGF-induced differentiation. Our results are consistent with a model in which Tat-mediated Id1 promoter activity in the absence of serum leads to the upregulation of Id1 protein that is necessary for the serum-independent cell proliferation observed in PC12/Tat cells (Figure 7 ). In addition, we identified at least one pathway that leads to upregulation of Id1 upon addition of NGF. It involves the phosphorylation of Stat5a leading to the activation of Id1 expression and blockage of neuronal differentiation. On the other hand, our data on NGF-induced phosphorylation of Sta5b provide a new avenue for the control of PC12 cell proliferation and differentiation. In addition, the profile of gene expression in Tat-expressing cells had shown marked increase of genes necessary for proliferation and downregulation of genes related to differentiation (de la Fuente et al., 2002) . It was hypothesized that the shut down of growth factor receptors observed in Tat-expressing cells may be a functional event that allows HIV-1-infected cells to avoid extracellular differentiation signals normally regulated by receptors (de la Fuente et al., 2002) . In the absence of a noticeable change in the levels of TrkA expression in PC12 cells, it is likely that Tat-mediated blockage of cell differentiation involves a noncanonical activation of molecules such as Stat5a, which make the cells refractory to NGF stimulation. The antidifferentiation signal of Tat in mature neurons could result in the loss or reduction of neuronal processes, a common With respect to Tat-mediated enhancement of cell proliferation, recent studies suggest that cell proliferation and abnormal re-entry of neuronal cells in the cell cycle may lead to neuronal cell death seen in neurodegenerative disorders such as Alzheimer's disease (Klein et al., 2002) . In addition, one may speculate that Tatinduced proliferation of the differentiated neuronal cells, which may occur at the early stage of the disease, induces cellular defense mechanisms such as apoptosis, which is a common pathologic manifestation of HIV-1-associated dementia, at the later stage of the disease.
Materials and methods
Cell lines
PC12 and PC12-derived cell lines were grown on collagencoated plastic culture dishes in DMEM medium supplemented with 5% horse serum, 10% fetal bovine serum, 1% penicillin/ streptomycin and other appropriate antibiotics when required. NGF (murine NGF 2.5S, Invitrogen, Carlsbad, CA, USA) was used at a concentration of 50 ng/ml. The measurements of the length of neuronal-like processes represent an average length taken from a series of pictures of corresponding microscopic fields as described previously (Wang et al., 2003) .
Recombinant Tat
Highly purified, endotoxin-free Tat was kindly provided by Dr Rappaport (Temple University). The function of recombinant Tat was tested by transcriptional activation of the HIV-1 LTR (data not shown). For the luciferase assay, serum-starved PC12 cells were incubated with fresh SFM in the absence or presence of NGF and Tat (10 ng/ml) for 3 h. The assay was then performed as described below.
Retroviral transductions and plasmid transfections
The retroviral transduction method has been described previously (Peruzzi et al., 1999) . In brief, pLEGFP-N1 (Clontech Laboratories, Palo Alto, CA, USA) empty vector (pLEGFP-N1/EV) and pLEGFP-N1-Tat were used to transfect the Phoenix packaging cell line (Profection Mammalian Transfection Kit, Promega, Madison, WI, USA). The conditioned medium containing viral particles was collected 48 h post-transfection and used to infect PC12 cells. To generate pLXSP/Id1 retroviral vector, Id1 cDNA was PCR amplified from the pEMSII-Id1 plasmid. pMX-DN Stat5b (provided by Dr T Skorski, Temple University, Philadelphia, PA, USA) was used to generate a PC12/Tat/DN Stat5b cell line. Id1 antisense (Id1 AS) was obtained by PCR using pEMSII-Id1 plasmid as a template. The 224 bp PCR fragment inserted into pMSCVpac retroviral vector to create pMSCV/Id1 AS plasmid. The same PCR fragment was inserted into pMSCVneo retroviral vector in the sense orientation to create pMSCV/Id1 sense control plasmid. DN Stat5a (Stat5a truncated at the aa 750) was obtained by PCR using the plasmid pSG513Stat5a (a gift of M Buitenhuis, Utrecht, The Netherlands) (Caldenhoven et al., 1998) as a template. pMXpuroEGFP-Stat5a1*6 retroviral vector (gift of Dr T Kitamura) (Onishi et al., 1998) was used to create PC12/Stat5a1*6 cells.
To transfect PC12 and PC12-derived cells, we used the Fugene 6 system (Roche Applied Science, Indianapolis, IN, USA) following the manufacturer's instructions. Fugene 6 was used in a 6 : 1 ratio (6 ml Fugene 6 : 1 mg DNA) and incubated with DMEM without serum at room temperature for 30 min before adding to the plate.
Survival and growth in soft agar
Exponentially growing cells were plated at a density of 5 Â 10 4 on 35 mm collagen-coated dishes in complete medium. The next day cells were washed twice with Hank's balanced salt solution and incubated with SFM (DMEM containing 2 mM glutamine and 0.1% BSA), SFM and NGF (50 ng/ml) or SFM and 10% fetal bovine serum (FBS). After 48, 96 and 120 h, viable cells were counted by trypan blue exclusion. For soft agar assay, we followed the previously described method (Reiss et al., 1998) . In brief, cells were seeded at 5 Â 10 3 per 30 mm plate in DMEM supplemented with 10% FBS and 0.1% agarose with 0.2% agarose under-layer, and scored for the ability to form colonies in soft agar 3 weeks later. Only colonies larger than 125 mM in diameter were counted.
Western blots
PC12 and PC12-derived cells were lysed with RIPA buffer (50 mM Tris pH 7.4, 1% NP-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM PMSF, 1 mM sodium orthovanadate and protease inhibitor cocktail; Sigma, St Louis, MO, USA). Of the whole-cell lysate, 50 mg were separated on a 4-15% sodium dodecyl sulfate-polyacrylamide gel (SDS-PAGE) (BioRad, Hercules, CA, USA). To detect phosphorylated Stat5, cells were pretreated with 10 mM Na 3 VO 4 for 30 min prior to the addition of NGF (50 ng/ml) for 10 min, washed with cold phosphate-buffered saline (PBS) containing 10 mM Na 3 VO 4 and finally lysed with RIPA buffer. Anti-phospho-Stat5 was from Cell Signaling (Cell Signaling Technology, Inc., Beverly, MA, USA). Total amount of Stat5 was detected using an antibody to the central portion of Stat5 (BD Transduction Laboratories, San Diego, CA, USA), or the combination of anti-Stat5a (L-20) and Stat5b (N-20) antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA). To detect the expression of Tat, about 1.5 Â 10 6 PC12/EV and PC12/Tat cells were lysed in Laemmli buffer and proteins were separated on a 15% PAGE. Proteins were then transferred for 10 min at 100 V. Anti-Tat antibody BH10 was obtained from NIH AIDS Research and Reference Reagent Program, NIH, Bethesda, MD, USA. Anti-Id1 was obtained from Santa Cruz. Anti-Grb2 was from BD Transduction Laboratories.
Northern blots
Serum-starved PC12, PC12/EV and PC12/Tat cells were harvested at various time points from NGF addition (50 ng/ ml). RNA was isolated with the RNeasy mini kit (Qiagen, Valencia, CA, USA). The probe was the PCR-amplified 1 kb fragment of Id1 from the pEMSII-Id1 plasmid described previously. The membranes were subsequently stripped and reprobed with GAPDH.
S.c. growth
Immunodeficient NIH Swiss mice were injected s.c. with PC12 or PC12-derived cell lines at cell density of 0.5 Â 10 7 in 100 ml, according to procedures described previously (Reiss et al., 2001) . In brief, male NIH Swiss nude mice were injected s.c. in the lower neck area with PC12, PC12/EV or PC12/Tat cell lines. The size of the tumors was subsequently evaluated on a weekly basis by measuring tumor diameter, and at the end of the experiment (3 weeks), the animals were killed and the HIV-1 Tat and neuronal signaling V Bergonzini et al tumors were weighed. The experiments were repeated three times in triplicate.
Luciferase assay pGL3-luc-Id1 (a gift from Dr R Baserga, T Jefferson University, Philadelphia, PA, USA) and pCMV-b-gal are described elsewhere (Nehlin et al., 1997; Belletti et al., 2002) . PC12 cells were plated at 0.5 Â 10 6 on 35 mm collagen-coated plates and cotransfected with 1 mg of pGL3-luc-Id1 plasmid and 0.5 mg of pCMV-b-gal in the absence of serum using Fugene 6 system. On day 2 post-transfection, the medium was replaced with SFM in the absence or presence of NGF (50 ng/ ml). Cells were harvested 3 h following the addition of NGF and lysed according to the manufacturer's instruction (Luciferase assay, Promega, Madison, WI, USA). The same lysate was analysed for b-galactosidase activity to normalize the efficiency of transfection (Promega, Madison, WI, USA).
Statistical analysis
The length of neuron-like processes was evaluated by utilizing phase-contrast images and by Image J software (version 1.240). Results represent an average of three independent experiments consisting of two plates per cell line from which measurements were taken in three separate microscopic fields (n ¼ 24). Statistical significance for comparison between groups of data was determined by using the unpaired, twotailed Student's t-test.
